Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Taylor-Cousar

Concepts (323)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
118
2025
1114
22.230
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
72
2025
329
14.990
Why?
Quinolones
29
2025
137
8.780
Why?
Aminophenols
44
2025
156
8.700
Why?
Benzodioxoles
30
2025
115
6.070
Why?
Chloride Channel Agonists
28
2025
84
4.950
Why?
Sinusitis
12
2025
221
3.920
Why?
Indoles
19
2025
412
3.280
Why?
Rhinitis
10
2025
158
3.080
Why?
Olfaction Disorders
8
2025
63
2.340
Why?
Pyrazoles
17
2025
423
2.160
Why?
Aminopyridines
6
2025
98
2.090
Why?
Drug Combinations
24
2025
343
1.950
Why?
Pyrrolidines
12
2025
79
1.940
Why?
Mutation
34
2024
3958
1.930
Why?
Membrane Transport Modulators
3
2020
7
1.860
Why?
Pongo pygmaeus
3
2024
7
1.830
Why?
Pyridines
15
2025
506
1.770
Why?
Pregnancy Complications
5
2024
527
1.700
Why?
Ape Diseases
3
2024
7
1.580
Why?
Reproductive Health
9
2024
90
1.390
Why?
Pregnancy Outcome
6
2024
416
1.310
Why?
Azithromycin
7
2021
100
1.310
Why?
Humans
127
2025
137585
1.240
Why?
Quality of Life
17
2025
2892
1.210
Why?
Pregnancy
20
2025
6763
1.150
Why?
Parents
5
2024
1347
1.130
Why?
Respiratory System Agents
2
2020
22
1.120
Why?
Reproductive Techniques, Assisted
3
2025
37
1.110
Why?
Adult
61
2025
37929
1.050
Why?
Paranasal Sinuses
5
2024
80
0.980
Why?
Female
73
2025
73304
0.950
Why?
Fetal Therapies
1
2025
42
0.920
Why?
Sexual Health
5
2024
59
0.890
Why?
Pseudomonas Infections
9
2024
225
0.890
Why?
Drug Approval
3
2024
88
0.880
Why?
Anti-Bacterial Agents
12
2024
1809
0.870
Why?
Pregnancy Rate
3
2021
65
0.870
Why?
Chronic Disease
14
2025
1793
0.850
Why?
Pongo
2
2021
6
0.850
Why?
Prospective Studies
16
2025
7604
0.710
Why?
Lung Transplantation
1
2024
313
0.710
Why?
Quinolines
6
2025
178
0.710
Why?
Diabetes Mellitus
2
2022
1040
0.700
Why?
Treatment Outcome
23
2025
10811
0.700
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
21
0.690
Why?
Glucose Intolerance
2
2025
146
0.690
Why?
Male
57
2025
67762
0.670
Why?
Sweat
9
2025
47
0.660
Why?
Compassionate Use Trials
1
2019
7
0.650
Why?
Smell
4
2025
117
0.640
Why?
Aerosols
1
2020
176
0.640
Why?
Lung
9
2023
4060
0.630
Why?
Drug Monitoring
6
2020
218
0.630
Why?
Sputum
5
2022
311
0.610
Why?
Fertility
3
2025
160
0.610
Why?
Genetic Therapy
4
2025
297
0.610
Why?
Precision Medicine
2
2021
429
0.610
Why?
Pseudomonas aeruginosa
9
2022
352
0.600
Why?
Forced Expiratory Volume
11
2023
531
0.560
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
250
0.550
Why?
Aldehyde Oxidoreductases
1
2017
27
0.530
Why?
Breast Feeding
2
2022
440
0.530
Why?
Glucose Tolerance Test
2
2025
366
0.520
Why?
Child
24
2025
21935
0.520
Why?
Rifampin
1
2017
84
0.510
Why?
Pongo abelii
1
2016
2
0.500
Why?
Biomedical Research
3
2024
692
0.500
Why?
Chlorides
8
2025
136
0.490
Why?
Sildenafil Citrate
2
2014
58
0.470
Why?
Young Adult
23
2025
13209
0.470
Why?
Surveys and Questionnaires
11
2025
5778
0.460
Why?
Adolescent
25
2025
21513
0.450
Why?
Bronchiectasis
1
2016
111
0.450
Why?
Tobramycin
5
2019
52
0.450
Why?
Leukocyte Elastase
1
2014
76
0.450
Why?
Infertility, Male
2
2025
61
0.440
Why?
Prenatal Exposure Delayed Effects
1
2020
605
0.420
Why?
Respiratory Function Tests
6
2025
600
0.380
Why?
Double-Blind Method
10
2025
1993
0.380
Why?
Lactation
3
2022
181
0.370
Why?
Contraception Behavior
2
2025
102
0.370
Why?
Homozygote
4
2021
203
0.350
Why?
Genotype
8
2025
1916
0.350
Why?
Contraception
2
2025
161
0.340
Why?
Drug Interactions
4
2020
410
0.320
Why?
Hypoventilation
1
2009
11
0.310
Why?
International Cooperation
2
2020
198
0.310
Why?
Respiratory Muscles
1
2009
33
0.310
Why?
Alleles
8
2025
891
0.310
Why?
Blood Glucose
3
2025
2186
0.300
Why?
ABO Blood-Group System
1
2009
51
0.300
Why?
Parenting
2
2023
310
0.290
Why?
Clinical Trials as Topic
3
2025
1050
0.290
Why?
Tomography, X-Ray Computed
4
2022
2691
0.270
Why?
Needs Assessment
2
2020
376
0.270
Why?
Middle Aged
20
2025
33479
0.240
Why?
Phenylpropionates
1
2025
19
0.240
Why?
Polymorphism, Genetic
1
2009
660
0.240
Why?
Asthma
3
2024
2295
0.240
Why?
Observational Studies as Topic
2
2024
117
0.240
Why?
Off-Label Use
1
2025
52
0.230
Why?
United States
10
2025
14841
0.230
Why?
Oligonucleotides, Antisense
1
2025
112
0.230
Why?
Animals
10
2024
36940
0.230
Why?
Fertility Preservation
1
2024
49
0.220
Why?
Minimal Clinically Important Difference
1
2023
16
0.220
Why?
Infant, Newborn
4
2024
6079
0.210
Why?
Food Preferences
1
2025
119
0.210
Why?
Orphan Drug Production
1
2023
5
0.210
Why?
Pregnancy, Unplanned
2
2023
48
0.210
Why?
C-Reactive Protein
2
2018
410
0.210
Why?
Patient Selection
2
2019
696
0.210
Why?
Abortion, Spontaneous
1
2023
105
0.200
Why?
Ion Transport
2
2021
60
0.200
Why?
Body Height
1
2023
199
0.200
Why?
Biomarkers
5
2024
4149
0.200
Why?
Neonatal Screening
1
2024
169
0.200
Why?
Respiratory Tract Diseases
1
2024
184
0.200
Why?
Puberty
1
2023
146
0.190
Why?
Azabicyclo Compounds
1
2021
6
0.190
Why?
Epoxide Hydrolases
1
2021
13
0.180
Why?
Enzyme Activators
1
2021
9
0.180
Why?
Benzoates
1
2021
43
0.180
Why?
Dose-Response Relationship, Drug
2
2017
2057
0.180
Why?
RNA, Messenger
3
2022
2833
0.180
Why?
Men's Health
1
2020
7
0.180
Why?
Endoscopy
4
2024
318
0.170
Why?
Infertility
1
2021
55
0.170
Why?
Multicenter Studies as Topic
1
2022
310
0.170
Why?
Women's Rights
1
2020
4
0.170
Why?
Retrospective Studies
10
2024
15657
0.170
Why?
Disease Progression
5
2020
2757
0.170
Why?
Communicable Disease Control
1
2020
82
0.160
Why?
Virulence Factors
2
2014
167
0.160
Why?
Cataract
1
2022
213
0.160
Why?
Aztreonam
2
2016
10
0.160
Why?
Colistin
1
2019
9
0.160
Why?
Health Knowledge, Attitudes, Practice
2
2025
1329
0.160
Why?
Neutrophils
3
2016
1238
0.160
Why?
Sexism
1
2020
61
0.160
Why?
Follow-Up Studies
3
2024
5131
0.160
Why?
Medication Therapy Management
1
2020
76
0.150
Why?
Receptors, Interleukin-8B
1
2018
26
0.150
Why?
Health Status
1
2023
792
0.140
Why?
Patient Reported Outcome Measures
1
2022
402
0.140
Why?
Administration, Oral
1
2020
816
0.140
Why?
Mental Health
1
2024
726
0.140
Why?
Pyrimidines
1
2021
470
0.140
Why?
Research Design
1
2024
1139
0.140
Why?
Severity of Illness Index
5
2021
2828
0.140
Why?
Cytochrome P-450 CYP3A Inducers
1
2017
6
0.140
Why?
Pregnancy, High-Risk
1
2017
14
0.130
Why?
HEK293 Cells
1
2020
730
0.130
Why?
Leukocytes
1
2018
311
0.130
Why?
Longitudinal Studies
1
2024
2844
0.130
Why?
Risk Assessment
3
2021
3457
0.130
Why?
Biological Availability
1
2017
148
0.130
Why?
Respiratory Tract Infections
1
2021
390
0.130
Why?
Research
1
2020
451
0.130
Why?
Biphenyl Compounds
1
2017
63
0.130
Why?
Risk Adjustment
1
2017
78
0.130
Why?
Health Services Accessibility
2
2024
986
0.130
Why?
Prognosis
2
2022
4030
0.130
Why?
Methicillin-Resistant Staphylococcus aureus
1
2019
234
0.120
Why?
Recovery of Function
1
2020
653
0.120
Why?
Gene Expression Profiling
3
2018
1774
0.120
Why?
Albuterol
1
2016
110
0.120
Why?
Attitude of Health Personnel
1
2023
1171
0.120
Why?
Pharmacogenetics
1
2017
180
0.120
Why?
Machine Learning
1
2020
493
0.120
Why?
Pilot Projects
2
2020
1710
0.120
Why?
Child, Preschool
3
2024
11074
0.120
Why?
Interferons
1
2016
202
0.110
Why?
Diabetes Complications
1
2016
227
0.110
Why?
Epithelial Cells
2
2020
1096
0.110
Why?
Adrenal Cortex Hormones
1
2018
565
0.110
Why?
Cyclopropanes
2
2025
90
0.110
Why?
Phosphodiesterase 5 Inhibitors
1
2014
37
0.110
Why?
Metalloproteases
1
2014
43
0.110
Why?
DNA Mutational Analysis
1
2015
399
0.110
Why?
Staphylococcal Infections
1
2019
400
0.110
Why?
Bronchodilator Agents
1
2016
252
0.110
Why?
Quorum Sensing
1
2014
77
0.110
Why?
Genetic Predisposition to Disease
2
2015
2426
0.110
Why?
Body Mass Index
2
2023
2389
0.100
Why?
Administration, Inhalation
3
2022
688
0.100
Why?
Wound Infection
1
2013
32
0.100
Why?
Neutrophil Activation
1
2013
80
0.100
Why?
Mycobacterium Infections
1
2013
63
0.100
Why?
Cellular Structures
1
2011
6
0.090
Why?
Comorbidity
1
2016
1622
0.090
Why?
Mycobacterium
1
2013
108
0.090
Why?
Blood Glucose Self-Monitoring
1
2016
641
0.090
Why?
Extracellular Space
1
2011
119
0.090
Why?
Microbial Viability
1
2011
91
0.090
Why?
Drug Therapy, Combination
3
2021
1066
0.090
Why?
Patient Admission
1
2012
197
0.080
Why?
Risk Factors
3
2020
10388
0.080
Why?
Leukocytes, Mononuclear
1
2013
558
0.080
Why?
Infant
1
2024
9465
0.080
Why?
Survival Rate
2
2018
1972
0.080
Why?
Blood Group Antigens
1
2009
15
0.080
Why?
Aged
5
2024
23961
0.080
Why?
Cardiovascular Diseases
1
2021
2111
0.070
Why?
Inflammation
2
2022
2837
0.070
Why?
Burns
1
2013
325
0.070
Why?
Mucus
1
2009
79
0.070
Why?
Mass Screening
1
2016
1287
0.070
Why?
Inpatients
1
2012
500
0.070
Why?
ADP Ribose Transferases
1
2007
9
0.070
Why?
Exotoxins
1
2007
16
0.070
Why?
Furin
1
2007
14
0.070
Why?
Sexual Behavior
2
2022
485
0.070
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2007
17
0.070
Why?
Oxygen Inhalation Therapy
1
2009
157
0.070
Why?
Time Factors
3
2024
6828
0.070
Why?
Cyclic GMP
1
2007
93
0.070
Why?
Bacterial Toxins
1
2007
106
0.070
Why?
Gene Expression Regulation
1
2016
2607
0.070
Why?
Phenotype
1
2015
3196
0.070
Why?
Sulfones
1
2007
110
0.060
Why?
Registries
3
2023
2035
0.060
Why?
Survivors
1
2010
493
0.060
Why?
Respiratory System
1
2007
157
0.060
Why?
Quinoxalines
1
2025
66
0.060
Why?
Respiratory Mucosa
1
2007
321
0.060
Why?
Piperazines
1
2007
350
0.060
Why?
European Union
1
2024
12
0.060
Why?
Respiration, Artificial
1
2009
645
0.060
Why?
Standard of Care
1
2024
72
0.050
Why?
Reproductive Health Services
1
2023
19
0.050
Why?
Cross-Sectional Studies
2
2025
5472
0.050
Why?
Logistic Models
2
2019
2074
0.050
Why?
Nose
1
2023
67
0.050
Why?
United States Food and Drug Administration
1
2024
208
0.050
Why?
Anemia, Iron-Deficiency
1
2024
58
0.050
Why?
Cell Separation
2
2016
318
0.050
Why?
Deoxyribonuclease I
1
2022
39
0.050
Why?
Saline Solution, Hypertonic
1
2022
41
0.050
Why?
Rare Diseases
1
2023
104
0.050
Why?
Sex Education
1
2022
30
0.050
Why?
Social Class
1
2024
282
0.050
Why?
Hot Flashes
1
2023
87
0.050
Why?
Contraceptive Agents
1
2022
66
0.050
Why?
Microbial Sensitivity Tests
2
2014
361
0.050
Why?
Iron
1
2024
313
0.050
Why?
Health Status Disparities
1
2024
289
0.040
Why?
Biofilms
2
2014
260
0.040
Why?
Polymorphism, Single Nucleotide
1
2009
2189
0.040
Why?
Preconception Care
1
2021
43
0.040
Why?
Nutritional Status
1
2023
350
0.040
Why?
Genetic Counseling
1
2021
77
0.040
Why?
Social Determinants of Health
1
2024
267
0.040
Why?
Attitude
1
2022
259
0.040
Why?
Societies, Medical
1
2024
820
0.040
Why?
Longevity
1
2021
165
0.040
Why?
Contraceptives, Oral, Hormonal
1
2020
33
0.040
Why?
Menopause
1
2023
320
0.040
Why?
Condoms
1
2020
103
0.040
Why?
Ambulatory Care
1
2023
546
0.040
Why?
Tetraspanin 30
1
2018
10
0.040
Why?
Sequence Analysis, DNA
1
2022
812
0.040
Why?
Administration, Intravenous
1
2019
155
0.040
Why?
British Columbia
1
2018
21
0.040
Why?
Genetic Testing
1
2021
460
0.040
Why?
Sex Factors
1
2024
2071
0.040
Why?
Ecosystem
1
2023
596
0.040
Why?
Diabetes Mellitus, Type 2
1
2012
2531
0.040
Why?
Healthcare Disparities
1
2024
654
0.040
Why?
trans-Golgi Network
2
2007
13
0.030
Why?
Case-Control Studies
2
2016
3556
0.030
Why?
Nitric Oxide Synthase Type II
2
2007
173
0.030
Why?
Gene Deletion
1
2018
391
0.030
Why?
Morbidity
1
2018
324
0.030
Why?
Drug Administration Routes
1
2016
38
0.030
Why?
Cells, Cultured
2
2018
4193
0.030
Why?
Genetic Variation
1
2021
991
0.030
Why?
Leadership
1
2020
388
0.030
Why?
Interferon-alpha
1
2016
198
0.030
Why?
Medication Adherence
1
2018
467
0.030
Why?
Practice Patterns, Physicians'
1
2023
1313
0.030
Why?
Depression
1
2024
1397
0.030
Why?
Colorado
2
2018
4565
0.030
Why?
Drug Resistance, Multiple, Bacterial
1
2014
78
0.030
Why?
Kaplan-Meier Estimate
1
2016
889
0.030
Why?
Rats
1
2022
5647
0.030
Why?
Odds Ratio
1
2016
1070
0.030
Why?
Survival Analysis
1
2016
1325
0.030
Why?
Cohort Studies
1
2023
5742
0.030
Why?
Ciprofloxacin
1
2013
29
0.030
Why?
Multivariate Analysis
1
2016
1509
0.020
Why?
Superoxides
1
2013
202
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2013
346
0.020
Why?
Drug Synergism
1
2013
382
0.020
Why?
Suspensions
1
2011
36
0.020
Why?
Cell Line
2
2007
2847
0.020
Why?
Enteral Nutrition
1
2012
202
0.020
Why?
Cell Adhesion
1
2011
466
0.020
Why?
Age Distribution
1
2010
392
0.020
Why?
Sex Distribution
1
2010
375
0.020
Why?
Aged, 80 and over
1
2021
7635
0.020
Why?
Age of Onset
1
2010
518
0.020
Why?
Insulin Infusion Systems
1
2012
394
0.020
Why?
Predictive Value of Tests
1
2013
2031
0.020
Why?
Feedback, Physiological
1
2007
77
0.020
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2007
22
0.020
Why?
Epithelial Sodium Channels
1
2007
20
0.020
Why?
Guanylate Cyclase
1
2007
37
0.020
Why?
Sodium
1
2007
217
0.020
Why?
Purines
1
2007
176
0.020
Why?
Hydrogen-Ion Concentration
1
2007
560
0.020
Why?
In Vitro Techniques
1
2007
1092
0.010
Why?
Transforming Growth Factor beta
1
2007
480
0.010
Why?
Patient Acceptance of Health Care
1
2010
806
0.010
Why?
Hypoglycemic Agents
1
2012
1291
0.010
Why?
Mice
2
2013
17787
0.010
Why?
Disease Models, Animal
1
2013
4295
0.010
Why?
Nitric Oxide
1
2007
915
0.010
Why?
Mice, Transgenic
1
2007
2167
0.010
Why?
Insulin
1
2012
2409
0.010
Why?
Macrophages
1
2007
1547
0.010
Why?
Signal Transduction
1
2007
5079
0.010
Why?
Taylor-Cousar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)